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Abstract
Background: Systematic reviews evaluating complex interventions often encounter substantial clinical
heterogeneity in intervention components and implementation features making synthesis challenging. Qualitative
comparative analysis (QCA) is a non-probabilistic method that uses mathematical set theory to study complex
phenomena; it has been proposed as a potential method to complement traditional evidence synthesis in reviews
of complex interventions to identify key intervention components or implementation features that might explain
effectiveness or ineffectiveness. The objective of this study was to describe our approach in detail and examine the
suitability of using QCA within the context of a systematic review.
Methods: We used data from a completed systematic review of behavioral interventions to improve medication
adherence to conduct two substantive analyses using QCA. The first analysis sought to identify combinations of
nine behavior change techniques/components (BCTs) found among effective interventions, and the second analysis
sought to identify combinations of five implementation features (e.g., agent, target, mode, time span, exposure)
found among effective interventions. For each substantive analysis, we reframed the review’s research questions to
be designed for use with QCA, calibrated sets (i.e., transformed raw data into data used in analysis), and identified
the necessary and/or sufficient combinations of BCTs and implementation features found in effective interventions.
Results: Our application of QCA for each substantive analysis is described in detail. We extended the original
review findings by identifying seven combinations of BCTs and four combinations of implementation features that
were sufficient for improving adherence. We found reasonable alignment between several systematic review steps
and processes used in QCA except that typical approaches to study abstraction for some intervention components
and features did not support a robust calibration for QCA.
Conclusions: QCA was suitable for use within a systematic review of medication adherence interventions and
offered insights beyond the single dimension stratifications used in the original completed review. Future
prospective use of QCA during a review is needed to determine the optimal way to efficiently integrate QCA into
existing approaches to evidence synthesis of complex interventions.
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Background
Systematic reviews evaluating complex or multicompo-
nent interventions often encounter substantial clinical
heterogeneity in intervention components, settings, and
populations studied, which often contribute to hetero-
geneity of effect size. Complex interventions are those
that include multiple components that often but do not
necessarily interact with each other [1–4]. The UK
Medical Research Council suggests that characteristics
such as the number and difficulty of behaviors required
by those delivering or receiving the intervention, the
number and variability of targeted outcomes, and the de-
gree of flexibility of tailoring of the intervention all con-
tribute to an intervention’s complexity [5]. In addition to
the number of components an intervention has, com-
plexity can also refer to properties of the system in
which an intervention is implemented, such as setting,
number of actors involved, and intervention target char-
acteristics [6, 7]. Further, an intervention may employ
multiple and varied implementation strategies [7]. As a
result of these myriad sources of potential variation,
complex interventions with a common underlying pur-
pose may differ quite substantially from each other in
form or function when implemented.
Accordingly, systematic review investigators face sub-
stantial methodological challenges to synthesizing bodies
of evidence comprised of complex interventions [7]. Esti-
mating summary effects via quantitative synthesis is often
not possible because of heterogeneity. Reviewers may ig-
nore underlying variation by only addressing an overall
question of effectiveness (e.g., do these types of interven-
tions work?), or reviewers may stratify the synthesis based
on one or more aspects of variation, such as a specific
intervention component, outcome, population, or setting
[7]. However, multicomponent interventions with inter-
dependent components may not be suitable for separation
into distinct components, and assumptions about linear
and additive effects of multiple components may not be
valid [8]. Methods that can systematically explore hetero-
geneity based on an assumption of causal complexity and
that can provide an analytic link between heterogeneity
and outcomes would offer an enhancement to current sys-
tematic review methods.
Qualitative comparative analysis (QCA) is a case-
oriented method to study complex phenomena originat-
ing from the comparative social sciences [9]; it has been
proposed as a potential method for synthesizing evi-
dence within systematic reviews [7, 10]. QCA uses math-
ematical set theory, which is the branch of mathematical
logic that studies the properties of sets, to examine set
relationships between combinations of condition sets
(cf., explanatory variables) present among cases and an
outcome set (cf., dependent variable). QCA can be useful
for identifying complex (i.e., non-linear, non-additive)
causal patterns that variable-oriented methods may miss
[9, 11, 12]. Applying QCA within the context of a sys-
tematic review may enhance review findings for policy-
makers and practitioners by systematically evaluating
sources of heterogeneity that influence the success (or
failure) of an intervention using an approach that pre-
serves each study’s unique combination of intervention
components or other features. How to apply QCA
within the context of a systematic review and the suit-
ability of the method for this context is not definitively
known because few actual applications exist [13, 14].
Based on our experience conducting systematic reviews
and our experience using QCA in primary research ap-
plications, we postulated that using QCA could offer
additional insights within a systematic review of a com-
plex intervention beyond traditional synthesis.
In this paper, we describe using QCA within a system-
atic review and examine its suitability for use within this
context. We used data from an Agency for Healthcare
Quality and Research (AHRQ)-sponsored review of in-
terventions to improve medication adherence that was
recently completed by members of our study team
(M.V., C.G.) [15, 16]. Medication adherence is a complex
behavior with multiple determinants that vary among in-
dividuals [17]. Interventions to improve adherence often
involve combinations of behavior change techniques
(BCTs), such as interventions to improve self-efficacy or
change attitudes. They often use different delivery modes
(e.g., telephone vs. in-person) and agents (e.g., physi-
cians, nurses, non-licensed staff ) over various intervals
of time and at different intensities. Further, interventions
may be designed to influence patient adherence through
interventions targeted at the practitioner or healthcare
system level in addition to patient-directed components.
We chose this review to use with QCA because the het-
erogeneity among interventions and outcomes seemed
amenable to exploration through a configural lens and
because we had access to all of the raw data and institu-
tional knowledge associated with the review.
We turned to QCA because too much clinical heterogen-
eity had precluded a meta-analysis and meta-regression.
Further, the completed review did not attempt mixed-
treatment comparisons because of heterogeneity in the
usual-care comparators [18]. However, all of the aforemen-
tioned approaches are correlational in nature, based on the
assumption that one true distribution of effect exists and
that trial-level covariates independently and additively con-
tribute to variation from the true effect. QCA is not a sub-
stitute for these quantitative approaches to synthesis when
they are appropriate, but these methods may rarely be ap-
propriate for complex interventions because of the under-
lying assumptions upon which they are based. Thus, QCA
offers a systematic approach to potentially unpacking inter-
vention variability and relationship to an outcome when
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the phenomena under investigation can be characterized as
complex.
Methods
We conducted two substantive analyses using QCA
using data that was collected as part of a completed re-
view. The first analysis sought to identify which combi-
nations of patient-directed BCTs used across the body of
evidence were necessary and/or sufficient for improving
medication adherence, and findings from this analysis
are presented in detail in a companion paper in this
issue [19]. The second analysis sought to identify which
combinations of implementation features (e.g., agent,
mode) used across the body of evidence were necessary
and/or sufficient for improving medication adherence. In
the present paper, we discuss the methodologic approach
applied to both analyses and highlight the added value
and challenges we identified through its application in a
systematic review.
Overview of QCA
Consistent with a case-oriented approach, QCA was ori-
ginally developed for use with a small to medium num-
ber of cases (N = 10 to 50), allowing researchers to
preserve the iterative nature of the data collection, ana-
lysis, and interpretation that stems from familiarity with
the cases, a hallmark of qualitative research. More re-
cently, QCA has been used for applications involving
larger sample sizes [12]. Used within a systematic review
context, each individual study within the review repre-
sents a case.
QCA preserves the holistic nature of each case
throughout the analysis by not deconstructing the case
into its component variables for analysis. Unlike
variable-oriented methods that are based on probabilistic
assumptions, QCA uses data from empiric cases to iden-
tify set relationships, which can be interpreted as rela-
tionships of “necessity” or “sufficiency” that often
characterize causally complex phenomena. These rela-
tionships are depicted as a solution that uses Boolean
operators, such as “AND,” “OR,” and “NOT,” to formu-
late verbal statements of the relationship between ex-
planatory variables (i.e., conditions in QCA terminology)
and an outcome. The solution generated by QCA is
analogous to the expression of a correlational relation-
ship among variables using a regression equation;
though unlike probabilistic methods, solutions do not
offer an estimate of precision, likelihood of finding re-
sults due to chance, nor can they be used for statistical
hypothesis testing. A truth table is the analytic device
used in QCA, and software is used to conduct most ana-
lyses [12, 20]. A detailed methodological description of
QCA, a hypothetical example of an analysis, and a
glossary of terms related to QCA is provided as supple-
mentary online material (Additional file 1).
Application of QCA to the completed review
Members of our study team (M.V., C.G.) conducted the
completed review using methods associated with the
AHRQ Effective Health Care Program (available at
http://www.ncbi.nlm.nih.gov/books/NBK47095/). The
completed review was limited to US studies in adults
with chronic conditions, excluding patients with HIV/
AIDS, severe mental illness, and substance abuse be-
cause these conditions often require specialized inter-
ventions not applicable to general medical populations
[15, 16]. Of 4124 citations identified in the completed
review, 758 full-text articles were screened for eligibility.
Of the 67 low- or medium-risk of bias studies included,
62 were randomized clinical trials and five were observa-
tional studies. Included studies were conducted among
patient populations with ten different clinical conditions.
Seven studies included populations with more than one
clinical condition. Study authors did not use consistent
language or a standard taxonomy to describe interven-
tion type; thus, the review team developed categories of
intervention types. Examples included “education with
behavioral support,” “health coaching,” “medication
monitoring and reminders,” “shared decision-making or
decision aids,” “case management,” and “collaborative
care.” Because of heterogeneity of populations and inter-
vention types, a quantitative synthesis was not possible.
The primary organizing framework for the qualitative
synthesis was clinical conditions (e.g., hypertension,
diabetes). Within each of the ten clinical conditions, ad-
herence outcomes were synthesized by intervention type.
For example, a low strength of evidence grade for benefit
was assigned for the use of case management interven-
tions among patients with diabetes based on evidence
from three RCTs. Overall, this approach resulted in 40
strata, each of which was assigned a strength of evidence
grade based on the one to five studies falling within the
stratum. The completed review’s analytic framework, key
questions, and a summary of the results are provided as
supplementary online material (Additional file 2). In
brief, this review found the most consistent evidence
for effectiveness across clinical conditions for inter-
ventions that included case management and educa-
tional interventions.
We developed an approach to using QCA within the
context of a systematic review based on existing stan-
dards of good practice for conducting QCA and our ex-
perience using the method in non-systematic review
applications [21–23]. This approach is depicted in Fig. 1,
and although the figure depicts this approach as sequen-
tial, in practice, iterative specification and analysis is typ-
ical and consistent with qualitative research approaches.
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Results
We will use the elements of Fig. 1 to summarize our
process of using QCA with systematic review data.
Specify configural research questions
As indicated in Fig. 1, we first specified a configural re-
search question, which is a question designed to identify
the combinations of conditions that produce an out-
come. For each substantive analysis, we specified a single
question that combined two of the completed review’s
key questions. These were key question 1: “Among pa-
tients with chronic diseases with self-administered medi-
cation prescribed by a provider, what is the comparative
effectiveness of interventions aimed at patients, pro-
viders, systems, and combinations of audiences in im-
proving medication adherence?” and key question 3:
“How do medication-adherence intervention characteris-
tics vary?” Further, we specified both of the configural
research questions to reflect causal asymmetry. The re-
specified research question for the first QCA was “What
combinations of behavioral change techniques are
present in studies demonstrating improved medication
adherence?” and for the second QCA was “What combi-
nations of implementation features, such as agent, tar-
get, mode, span, and exposure are present in studies
demonstrating improved medication adherence?”
Specify configural research questions: 
Which combinations of behavior change 
techniques and implementation features are 
necessary or sufficient, or both, for 
improving medication adherence?
Identify studies  (i.e., 











Analyze logical remainders 











Construct and analyze truth 
table
Fig. 1 QCA approach used in this analysis. Adapted from Kane et al. [22]
Kahwati et al. Systematic Reviews  (2016) 5:82 Page 4 of 12
Identify studies for use in analysis
We defined studies included in the systematic review as
the cases for each analysis. Based on how we operation-
alized the research questions, we excluded seven of the
67 studies from the completed review from both ana-
lyses as they were focused on policy or system level in-
terventions and not relevant to the conditions (BCTs
and implementation features) that we were interested in
exploring. We found that the process used for study se-
lection in a typical systematic review of interventions,
which defines inclusion and exclusion criteria using the
PICOTS framework (patient, intervention, comparator,
outcome, timing, and setting), ensured that the cases in-
cluded in the QCA were similar enough to be compar-
able, yet still offered enough diversity in intervention
design to enable understanding heterogeneity of effect.
Further, this approach provides an explicit and detailed
rationale for the selection (or non-selection) of cases,
which is a standard of good practice for conducting
QCA [21].
Specify and calibrate condition sets and outcome set
Because one of our study aims was to assess the suitabil-
ity of using QCA in a systematic review context, we used
a completed review to determine whether data typically
abstracted during a review would be acceptable to use
with QCA. Thus, our initial approach was to rely on the
review’s completed data abstraction files and published
evidence tables. However, we adjusted our approach dur-
ing the course of the analyses to verify and supplement
previously abstracted data as we needed additional infor-
mation not collected during the original review process.
Set calibration refers to the process of assigning a nu-
meric value between 0 and 1 based on data collected
from or about the case for each condition set and out-
come set included in an analysis. These values are re-
ferred to as set membership values and represent the
degree to which the case belongs to each of the sets in
the analysis. Researchers typically define the rubric that
determines what set membership value to assign based
on existing theory or information external to the cases
at hand. Qualitative and/or quantitative data collected
from a case is evaluated against the calibration rubric to
determine the specific set membership value that should
be assigned to the case. In a crisp-set (cf, binary) calibra-
tion scheme, cases are either assigned values of “1” (fully
in the set) or “0” (fully out of the set). For example,
when trying to establish whether an adherence interven-
tion belongs to the set of studies that are “theory-based,”
one could examine whether the intervention designers
described and cited specific behavioral theories that were
used to develop the intervention; if so, the study would
be assigned a 1, and if not, the study would be assigned
a 0. Non-binary calibration schemes are also possible
and are described in more detail in the online supple-
mentary material (Additional file 1).
Studies in the completed review used a variety of
medication adherence outcomes measured at various
time points based on self-report, prescription fills, or
medication event monitoring systems (“smart” medica-
tion bottles). Some studies used more than one measure
of adherence. We reviewed abstracted data and original
studies and determined that we would consider studies
to be fully in the set of studies with improved adherence
if at least one measure of adherence demonstrated a sta-
tistically significant improvement as compared to a
usual-care comparison group. We chose this calibration
rubric because of the lack of a common adherence
measure across studies. We considered using a fuzzy-set
calibration rubric, which allows for set membership
values between 0 and 1; but, the panoply of adherence
measures used both within and across studies and the
lack of external standards for defining differences in de-
gree of adherence (e.g., “very much improved adherence”
from “slightly improved adherence” from “slightly not
improved adherence”) proved too challenging.
Condition sets used in each analysis are summarized
in Table 1. The abstracted data and evidence tables that
described the BCTs and implementation features used in
studies generally provided inadequate information to en-
able us to calibrate condition sets; thus, we went back to
original study publications to obtain more detail and to
clarify ambiguous data abstraction entries for nearly all
studies.
The BCTs abstracted during the completed review
were determined and defined a priori by the review team
and derived from a previous meta-analysis of medication
adherence interventions and a published taxonomy of
BCTs [24, 25]. One study reviewer captured a study’s use
of each BCT as “yes” or “no” or “unclear” based on infor-
mation available in the published intervention descrip-
tion, and this was confirmed by a second reviewer.
Thus, studies could be identified as using multiple BCTs.
To studies that used a BCT, we assigned a set member-
ship value of 1 for that BCT, and we assigned studies
that did not use a BCT, or for which use of the BCT was
unclear, a set membership value of 0. We also conducted
sensitivity analyses with an alternate rubric that cali-
brated “unclear” as BCT use.
A challenge we encountered for the first analysis was
the large number (12) of BCTs identified during abstrac-
tion in the completed review. With this many condi-
tions, we were concerned about limited diversity that
would result by including too many condition sets for
the fixed number of studies (60). We winnowed the
number of included condition sets to nine by eliminating
three BCTs that were used by fewer than three studies.
We attempted to further reduce the number of BCTs
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included in analysis by combining two BCTs to create a
macrocondition, a typical strategy in QCA to reduce the
number of included condition sets. However, we found
the BCTs too conceptually distinct to combine into a
single macrocondition. Thus, we could not implement a
QCA standard of good practice with respect to keeping
the number of condition sets relative to the number of
cases at a reasonable level [21].
For the second analysis, which evaluated implementa-
tion features, we specified condition set-based imple-
mentation features that the completed review authors
determined a priori and captured during study abstrac-
tion. These features, listed in Table 1, included interven-
tion agent, target, span of intervention over time, mode
of delivery, and intervention exposure. Information about
these characteristics was captured by the review team
using unstructured abstraction fields. For three of the
condition sets, target, agent, and mode, the review team
collapsed abstracted data into multivalue, mutually ex-
clusive, categories for descriptive reporting of interven-
tion characteristics.
We evaluated whether the multivalue categorical
groupings for target, agent, and mode could be further
collapsed into dichotomous categories for a crisp-set
calibration rubric. For target, the review team used in-
formation from the published description to assign each
study to one of three categories: patient-only, combin-
ation of patient and provider, combination of patient
and provider and system. For our analysis, we decided
that the inclusion of a provider or system target, in
addition to targeting the patient, was a key distinction as
provider and system interventions would require add-
itional training, infrastructure, and expense. Thus, we
considered a study as “fully in” for the target condition
set if the intervention targeted a provider or system in
addition to a patient. Studies targeting only patients
were considered “fully out” of the set. Similarly for mode,
we first evaluated the completed review’s categorical
groupings before deciding that a key design feature rele-
vant to policy-makers and practitioners would be
whether the intervention was delivered in-person versus
some other mode (e.g., telephone, virtual, automated)
because of secular trends in virtual care, convenience to
patients, and perhaps lower costs. We developed two al-
ternatives to accommodate interventions with mixed
modes, where some of the intervention was delivered in
person and some delivered by phone or virtually. For
calibration of the agent condition set, we considered
studies that used licensed health care professionals (e.g.,
nurse, physician, pharmacist) as fully in, and studies that
used agents described as research assistants, health coa-
ches, or other non-licensed types of staff as fully out.
The calibration of the final two condition sets in the
second analysis, time span of intervention and intensity
of exposure, exemplified the iterative back and forth be-
tween theory and empirical information from the cases
at hand that is a QCA standard of good practice [21].
Study abstractors captured raw data about these two
condition sets in an unstructured format during the re-
view. We first transformed the raw data into standard-
ized numeric values such that time span was
represented in “weeks” from beginning to end of the
intervention and the total time spent exposed to the
intervention was represented in “minutes.” Because ex-
posure information in some studies lacked detail, we
made assumptions regarding average length of a clinic
visit, telephone contact, or time spent exposed to an au-
tomated intervention when it was not specifically pro-
vided. For simplicity in interpretation, we chose to
Table 1 Conditions sets used in two qualitative comparative
analyses (QCA) within an existing systematic review of
medication adherence interventions
Analysis 1
Behavior change techniques useda
Increasing knowledge—provision of general information about
behavior-related health consequences, use of individualized information,
increase in understanding/memory enhancement
Increasing awareness—risk communication, self-monitoring, reflective
listening, behavioral feedback
Providing facilitation—ongoing professional support, dealing with
adverse effects, individualizing/simplifying regimen (fewer pills, fewer
medications, less frequent dosing, timing of dosing to fit individual
schedule), reducing environmental barriers
Increasing self-efficacy—modeling, practice/skills training, verbal
persuasion, coping response, graded tasks, reattribution of success/failure
Supporting intention formation—general intention, medication
schedule, goals, behavioral contract
Increasing use of action control techniques—cues/reminders,
self-persuasion, social support
Changing attitudes—targeting attitudes toward adherence behaviors
Supporting behavior maintenance—setting maintenance goals,
relapse prevention
Using motivational interviewing—client-centered yet directive




Intervention agent—the entity interacting with the intervention
target to provide the intervention, for example health care professional,
research assistant, automated computer or phone agent
Intervention target—the entity receiving the intervention, for example
patient, provider, health care system, or combination
Span—the total length of time (in weeks) over which the intervention
was provided
Mode of delivery—the mechanism through which the intervention
was provided, for example in-person, over the phone, or virtually
(online, text message, email, chat room, etc.)
Exposure—the total dose of the intervention (in minutes)
aA total of 12 behavioral change techniques were evaluated and abstracted
during the completed review; we included these 9 in the QCA
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calibrate span and exposure with crisp sets. We contem-
plated various thresholds guided by the following
considerations:
1) Select the calibration threshold with some knowledge
of the range of values represented within our studies
to avoid setting it too high or too low such that most
studies would be in or out of the set.
2) Incorporate our substantive experience with
behavioral interventions regarding what would be
considered a threshold for a longer span or a higher
exposure, but convey the condition sets using their
numeric threshold value rather than terms such as
low or high to mitigate concerns over the inherent
arbitrariness of wherever we placed the threshold
(e.g., span >12 weeks is “in,” rather than “long span”
is “in”).
3) Test alternative thresholds in sensitivity analyses to
assess the robustness of our findings with respect to
the placement of the calibration threshold.
Ultimately, our main analysis used a calibration
threshold of greater than or equal to 12 weeks as fully in
the span condition set and a threshold of greater than or
equal to 120 min as fully in the exposure condition set.
In sensitivity analyses, we evaluated a span threshold of
6 weeks and two exposure thresholds, 60 and 240 min.
We identified some differences in findings, and all sup-
plemental analyses were made available as appendices to
the main substantive analysis to support transparency
and demonstrate the sensitivity of findings to changes in
calibration thresholds.
Construct and analyze the truth table
For each analysis, we transformed the raw data matrix of
set membership values into a truth table, which places
studies with the exact same configuration of set mem-
bership values for condition sets into the same truth
table row. The number of logically possible truth table
rows in an analysis is equal to 2k, where k is equal to the
number of included condition sets; thus, the truth table
for the first analysis contained 512 (i.e., 29) rows and the
table for the second analysis contained 32 rows (i.e., 25).
In both analyses, some of the truth table’s logically pos-
sible configurations were not present in any studies so
these rows are “empty” of any empiric cases and are
called logical remainders. The truth table is the analytic
device in QCA for determining which configurations of
condition sets consistently demonstrate the outcome. If
all studies within a truth table row demonstrate im-
proved adherence, then that row is coded as fully in or 1
with a consistency of 100 %. Rarely do real-world phe-
nomena exhibit perfect consistency. In QCA, rows with
a consistency of less than 100 % (also referred to as
contradictory rows) can still be coded as 1 and included
in sufficiency analyses if row consistency is above a pre-
specified level. Different thresholds for consistency can
be used based on the nature of the research question,
data quality, and number of cases, but typical thresholds
are between 75 and 90 % [21].
Using the truth table created for each analysis, we
identified set relationships between condition sets and
configurations of condition sets and the outcome set.
As described in the supplemental online materials
(Additional file 1), superset relationships between condi-
tion sets and an outcome set can be interpreted as indicat-
ing necessary conditions. Similarly subset relationships
between condition sets and an outcome set can be inter-
preted as indicating sufficient conditions. We used Stata
Version 13 (StataCorp, College Station, TX) to create
2 × 2 contingency tables using set membership values for
each condition set and the outcome set. Data from these
tables are interpreted through a set-theoretic lens, mean-
ing that the proportions produced by the table are inter-
preted as the consistency of each condition as a necessary
condition for the outcome (% of cases in the outcome set
that are also in the condition set) or as a sufficient condi-
tion for the outcome (% of cases in the condition set that
are also in the outcome set). In the first analysis, we iden-
tified one BCT (techniques that increase knowledge) as
individually necessary and one BCT (techniques that in-
crease self-efficacy) as individually sufficient; in the second
analysis, we did not identify any individually necessary or
sufficient conditions.
Though an assessment of individually necessary or suf-
ficient conditions is the initial analytic step, it is the
evaluation of configurations of condition sets that allows
QCA to offer powerful insights into complex causal pat-
terns. For a configuration of condition sets to be neces-
sary, it would need to be consistently present among all
studies with the outcome of “improved medication ad-
herence.” We did not identify two or more individual
necessary condition sets in either analysis, and because
formal logic prescribes that no configuration can be
considered necessary unless each individual compo-
nent condition set is necessary, we quickly discerned
that we would not need an assessment of necessary
configurations.
We used fsQCA version 2.5 to conduct sufficiency
analyses for configurations [26]. In crisp-set QCA, the
configuration of set membership values in each row of
the truth table where the outcome set is 1 represents as
expression of sufficiency. In other words, if the outcome
is consistently present among cases within the row, then
that unique combination of condition sets (i.e., presence
or absence of conditions in a crisp-set scheme) is a
sufficient pathway to the outcome. If multiple truth
table rows consistently demonstrate the outcome, then
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multiple sufficient pathways are present (i.e., an equifinal
solution). The most complex expressions of sufficiency
can be taken directly from truth table rows; however, these
statements are often unwieldy in the number of conditions
and operator terms (ANDs, ORs, NOTs), which makes
them difficult to interpret. These expressions can be logic-
ally minimized to simpler expressions with fewer terms
and operators that are still logically consistent with the
more complex expression, but easier to interpret.
The fsQCA software uses the Quine-McCluskey algo-
rithm to perform this minimization procedure. The basis
of this minimization procedure is that if two truth table
rows with the same outcome differ in set membership
value of only one condition set, then that condition set is
irrelevant for producing the outcome in that row and can
be eliminated. The two rows can be merged resulting in a
simpler expression of sufficiency. This algorithm is re-
peated such that all truth table rows are compared and re-
duced until no further simplification is possible. In
actuality, three variants of the minimization procedure are
used to produce three variants of a solution, the conserva-
tive, the intermediate, and the parsimonious solutions.
These three solutions are all logically consistent with each
other but represent different degrees of parsimony and
differ with respect to whether logical remainders are used
as part of the minimization procedure.
Ultimately, we identified seven sufficient configura-
tions in the intermediate solution for the first analysis
and four sufficient configurations for the second ana-
lysis. A summary of these results is in Tables 2 and 3.
We computed parameters of fit to describe how well the
set relationships we identified deviate from a perfect set
relationship (i.e., consistency) and how well the solutions
identified explain the outcome across all empiric cases
included (i.e., coverage). See the online supplementary
materials (Additional file 1) for additional information
regarding parameters of fit.
Make sense of the results
We examined the studies covered by configurations in
the identified solutions to narratively describe how these
solutions were represented within a study and across
studies for each analysis. The process of relating solution
findings back to the studies was instructive for identify-
ing the need for adjustments in condition set calibration.
This process also helped us to think beyond numeric
coverage levels when considering the relevance of the
various configurations to the outcome that we identified.
Table 2 Summary of findings from analysis 1 evaluating combinations of behavior change techniques used by effective adherence
interventions
Combinations of behavior change techniques Consistencyb (%) Coverage
Number of cases
(rawc (%)/uniqued (%))
Combination 1 Increasing knowledge AND enhancing self-efficacy 100 17 cases
(50/44)
Combination 2 Using motivational interviewing AND not using facilitation 100 4 cases
(12/6)
Combination 3 Enhancing self-efficacy AND using intention formation AND
improving attitudes AND not increasing awareness
100 2 cases
(6/0)
Combination 4 Using action control AND not increasing knowledge AND not
using facilitation AND not using maintenance strategies
100 1 case
(3/3)
Combination 5 Enhancing self-efficacy AND using intention formation AND




Combination 6 Increasing knowledge AND using facilitation AND increasing
awareness AND using intention formation AND using action
control AND not using maintenance strategies
100 2 cases
(6/6)
Combination 7 Increasing knowledge AND using facilitation AND improving
attitude AND not increasing awareness
100 3 cases
(9/9)
Solutiona (%) – 100 76
aThe solution is the conjunction of all combinations identified; solution coverage refers to the number of studies that include at least one of the identified
combinations of behavioral change techniques. The solution coverage for intermediate solution was 76 %, which means 26 of the 34 studies were represented by
one or more of the identified combinations, leaving 8 effective studies unexplained
bConsistency refers to the proportion of studies covered by sufficient combinations of behavioral change techniques that demonstrated improved adherence
cRaw coverage is the number of studies with the configuration of conditions (N varies by configuration) divided by the number of studies demonstrating
improved medication adherence (N = 34). Studies may be covered by more than one configuration because of the logical minimization that occurs to generate
more parsimonious combinations of conditions and condition complements. Raw coverage can vary between 0 and 100 %, with higher coverage representing
more empirical relevance
dUnique coverage is the number of studies that are only covered by the configuration (N varies by configuration) divided by the number of studies demonstrating
improved adherence (N = 34)
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For example, in the first analysis, we found configura-
tions that included the absence of various BCTs to be
less interpretable than configurations mostly character-
ized by the presence of BCTs since interventions are not
typically designed to explicitly exclude a BCT. Similarly,
the process of re-reviewing the studies in light of the so-
lutions they exemplified allowed us to reconsider the
relevance of the knowledge BCT condition set, which we
had identified as individually necessary. This condition
was present in 57 of the 60 studies we used for the QCA
and was generally exhibited within studies as providing
patients with information about their disease, the medi-
cation used to treat, and benefits and side effects of
treatment. Thus, membership in the knowledge BCT set
was heavily skewed, and knowledge would likely be a ne-
cessary condition of whatever outcome set we defined, a
concept described by QCA experts as a “trivial” neces-
sary condition [12]. Lastly, in keeping with standards of
good QCA practice, we repeated all analyses for the set
of studies (N = 26) not demonstrating improved ad-
herence [19].
Discussion
We used QCA within a systematic review to identify
combinations of BCTs and combinations of implementa-
tion features found among effective medication adher-
ence interventions. The 40 strength of evidence grades
in the completed review provided readers with a synthe-
sis of the magnitude and direction of effect for 40 small
groups of studies, each group characterized by the same
clinical condition and type of intervention [16]. The
QCA results we identified complement the completed
review findings by synthesizing across the boundaries of
clinical condition and typology to identify combinations
of BCTs and implementation features present among the
entire set of effective interventions. The QCA findings
Table 3 Summary of findings from analysis 2 evaluating combinations of implementation features used by effective adherence
interventions
Combinations of implementation features (agent, exposure, mode, time span, target) Consistencyb (%) Coverage
Number of cases
(rawc (%)/uniqued (%))
Combination 1 Agent: uses staff other than licensed health care professionals
AND
Target: patients plus provider and/or systems
100 6 cases
(18/12)
Combination 2 Agent: uses staff other than licensed health care professionals
AND
Exposure: less than 120 minutes
AND
Mode: no face to face component
AND
Time span: more than 12 weeks
88 8 cases
(21/15)
Combination 3 Agent: licensed health care professionals
AND
Exposure: more than 120 minutes
AND
Mode: includes a face to face component
AND
Time span: less than 12 weeks
100 4 cases
(12/12)
Combination 4 Agent: licensed health care professionals
AND
Exposure: more than 120 minutes
AND





Solutiona (%) 95 56
aThe solution is the conjunction of all combinations identified. Solution consistency refers to proportion of studies covered by sufficient combinations of
behavioral change techniques demonstrated improved adherence. Solution coverage refers to the number of studies that include at least one of the identified
combinations of implementation features. The solution coverage for intermediate solution was 56 %, which means 19 of the 34 studies were represented by one
or more of the identified combinations, leaving 15 effective studies unexplained. Alternative models using different calibration thresholds for exposure were also
conducted. Higher exposure threshold (>240 versus <240 min) resulted in slightly lower solution coverage (53 %) and consistency (90 %). Lower exposure
threshold (>60 versus <60 min) resulted in higher solution coverage (68 %) and consistency (100 %)
bConsistency refers to proportion of studies covered by each combination of implementation features that demonstrated improved adherence
cRaw coverage is the number of studies with the configuration of conditions (N varies by configuration) divided by the number of studies demonstrating
improved medication adherence (N = 34). Studies may be covered by more than one configuration because of the logical minimization that occurs to generate
more parsimonious combinations of conditions and condition complements. Raw coverage can vary between 0 and 100 %, with higher coverage representing
more empirical relevance
dUnique coverage is the number of studies that are only covered by the configuration (N varies by configuration) divided by the number of studies demonstrating
improved adherence (N = 34)
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are not a replacement for the findings in the completed
review; rather, they provide additional insights based on
configurational questions. Configurational questions are
often not formulated as review key questions or the evi-
dence is deemed insufficient to answer such questions
for a variety of reasons—for example, lack of trials with
direct comparisons of various different intervention fea-
tures. Yet, “what is the recipe for effectiveness?” is often
the information that practitioners and policy-makers
want to know when complex interventions and their
outcomes are heterogeneous.
We judged QCA to be suitable for use within system-
atic reviews based on the similarity of processes that are
already part of a typical evidence synthesis. In Table 4,
we provide our assessment of the alignment between
systematic review and QCA steps, specifically the identi-
fication of studies/cases to include, data collection,
study/case assessment, analysis, and presentation of
findings. Our retrospective application of the method
was inefficient, requiring re-review of the original studies
at various steps in the process. However, a retrospective
approach was invaluable for identifying challenges and
steps that might be required beyond a typical review
process in order to apply QCA. Although we identified
alignment at a number of steps, how best to present
findings within the review deserves further prospective
evaluation.
The alignment between systematic review processes
and QCA at the study/case assessment step deserves
highlighting because of the importance of this step for fi-
delity to standards of good QCA practice [21]. The dis-
tinction between the abstraction tasks of transcribing
information from studies into evidence tables and mak-
ing judgments about the use of various BCTs or imple-
mentation features based on information in the studies
was not well defined during the original review. Calibra-
tion of sets for QCA requires a clear rubric for making
set membership value assignments and a mechanism for
recording the rationale for the assignment, similar to the
approach used for risk of bias assessments. Making set
membership value assignments in tandem with data ab-
straction may be efficient; however, calibration rubrics
Table 4 Alignment between typical systematic review processes and a QCA process
Research step Systematic review process QCA process Alignment
Identification of cases
to include
Formalized process involving a replicable
literature search strategy and study
inclusion/exclusion criteria defined by
dimensions of population, intervention,
comparator, outcomes, timing, and
setting.
Non-mechanistic, researcher-directed
process that selects cases that share
enough background similarity yet
offer heterogeneity with respect
to explanatory conditions and the
outcome.
Good.
Data collection Information from included studies
abstracted and put into structured
evidence tables. Information abstracted
typically includes study setting,
population, intervention description,
and outcome estimates.
No standard approach, varies by
study, and dependent on the research
question and nature of data being
used.
Adequate, but could be inefficient if
QCA is not planned from the start.
Study/case assessment Risk of bias: based on researcher
assessment of study design and study
execution using standard assessment
domains.
Other elements: reviewer-assigned study
attributes based on assessment of
information in published study
description or provided from authors
in response to a query.
Calibration rubric guides process;
process should be transparent and
replicable based on rubric.
Not well aligned. Current review
processes may need strengthening to
support a robust calibration process.
Analysis Qualitative synthesis—narrative summary
with strength of evidence grade(s),
sometimes stratified for large or diverse
bodies of evidence.
Quantitative synthesis—meta-analytic
methods to produce summary effect
estimates for direct and sometimes
indirect comparisons. Meta-regression
to explore heterogeneity of effect.
Configurational based on
non-correlational analysis of set
relationships. Includes components
involving logical minimization of
truth table but also narrative summary
exploring cases identified in the
solutions generated.
Requires separate steps but should be
coordinated such that the analyses
complement each other.
Presentation of findings Typically involves text summary, along
with supporting detailed evidence
tables and figures supporting
quantitative synthesis (e.g., forest plots,
meta-regression figures) organized using
the key questions of the review’s analytic
framework.
Typically involves presentation of
solutions using symbolic notation
and Boolean operators in addition
to narrative description of findings.
In some cases, Venn diagrams,
or X-Y plots can be used to convey
findings.
Unclear. Need additional experience to
determine appropriate way to present
and integrate QCA findings in a typical
evidence report.
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cannot always be determined a priori, and the familiarity
with studies gained through abstraction may be helpful
for finalizing the rubric. Even the most robust calibration
processes may not overcome the paucity of information
about intervention components, implementation fea-
tures available in published study reports. We believe
this may be the biggest challenge to applying QCA and
encountered this issue in both our substantive analyses.
Ultimately, enough information about the study needs to
be available to support the set membership value assign-
ment, though sensitivity analyses could mitigate the im-
pact of missing information.
We identified several other applications of QCA
within systematic reviews. To date, all applications of
QCA to systematic reviews have been published and
presented in separate manuscripts, and not as part of
the main evidence report. Using data from a subset of
studies in a review of community engagement interven-
tions for public health and health promotion, Thomas
and Brunton et al. applied QCA to identify which com-
binations of community engagement methods directed
toward pregnant or new mothers were effective for pro-
moting breastfeeding [13, 27]. Although this study had
limited diversity and low solution coverage, the investi-
gators could derive additional meaning from the analysis
that went beyond the initial qualitative synthesis. We
agree with these authors’ assertions about the challenge
of finding the right balance between parsimony and
complexity when defining condition sets. Candy et al.
used QCA with a completed Cochrane systematic review
to explore relationships between what patients identify
as important components of interventions to improve
medication adherence for chronic clinical conditions
with what components are actually represented within
effective interventions [14]. The authors discuss the
challenge with the selection and processing of data that
is far removed from its primary source by the time it ap-
pears in a systematic review, a challenge we also ac-
knowledge and had not previously encountered in our
use of QCA within primary research studies. We concur
with the observations of both study authors regarding
the lack of intervention detail reported in primary stud-
ies limiting the robust application of QCA within a sys-
tematic review context.
Our experience is limited to conducting two analyses
within the same completed systematic review. Whether
QCA is feasible and adds value within reviews that in-
clude a smaller or larger numbers of studies or a review
that includes many different outcomes or studies where
interventions are complex but do not have easily dis-
cernible components is uncertain. The extent to which
this method could be applied to other systematic reviews
of complex interventions is determined by a number of
factors, some based on requirements of the method
itself. For example, variability in the outcome is essential
to this method; we selected the medication adherence
review to apply QCA in part because studies in the re-
view included interventions with demonstrated effective-
ness and interventions where effectiveness was not
demonstrated. Lastly, our study did not evaluate how to
present and integrate results from QCA within a trad-
itional qualitative or quantitative review in a way that
minimizes the need for an in-depth understanding of the
method, yet provides enough transparency for readers to
judge the validity and reliability of the findings.
We offer several recommendations for use of this
method in systematic reviews. First, ensure some of the
review research questions are configural and based on
an a priori understanding of the phenomenon under
evaluation. Reviews with fewer than ten studies may not
be good candidates for QCA because no more than two
to three condition sets can be accommodated without
creating substantial limited diversity and patterns among
condition sets may just as easily identified by “eye-balling.”
Finally, we recommend initial calibration rubric design
prior to study abstraction for efficiency, but teams should
plan to re-specify and re-review studies if needed before
making final calibration decisions.
Conclusion
In conclusion, QCA offers systematic reviewers an add-
itional tool for evidence synthesis in reviews of complex
interventions. Further prospective use of the method
during a review is needed to identify further areas for
process alignment, method refinement, and how best to
integrate and present results from a QCA into a typical
evidence synthesis report.
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